Previous work has demonstrated the involvement of HNRPK in cancer and its dual nature, behaving as both an oncogene and a tumor suppressor by directly regulating key molecules like p53 and c-MYC (16, 17). The gene discussed is HNRNPK; the disease is neoplasm.